Tamoxifen-related porphyria cutanea tarda

Medical Oncology

Volumn 19, Issue 2, 2002, Pages 121-123

  Nagai, Yoshinori ^a,c   Akashi, Sachiko ^a,b   Nagafuku, Masakazu ^b,d   Ogata, Masato ^e   Iwakura, Yoichiro ^a   Akira, Shizuo ^f   Kitamura, Toshio ^a   Kosugi, Atsushi ^b,d   Kimoto, Masao ^c   Miyake, Kensuke ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

Breast cancer; Estrogen; Nonalcoholic steatohepatitis; Porphyria cutanea tarda; Tamoxifen

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TAMOXIFEN; UROPORPHYRIN; ANTINEOPLASTIC AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER TOXICITY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; TOXIC HEPATITIS; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CASE REPORT; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMAN; MIDDLE AGE; PORPHYRIA CUTANEA TARDA; TAMOXIFEN; HUMANS; MIDDLE AGED;

EID: 0036017510     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:19:2:121     Document Type: Article

References (6)

1. Metabolic and nutritional disorders
2. Haemachromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
3. Porphyria cutanea tarda after neoplastic drugs
4. Tamoxifen and porphyria
5. 14C] tamoxifen to liver microsomes and the forms of cytochrome P450 involved
6. Non-alcoholic steatohepatitis (NASH): A disease of emerging importance